4,794
Views
74
CrossRef citations to date
0
Altmetric
Research Paper

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

ORCID Icon, , , , , , , ORCID Icon, , , , , , , & show all
Pages 530-539 | Received 07 Jun 2018, Accepted 25 Sep 2018, Published online: 16 Jan 2019

Figures & data

Table 1. Subjects reporting local and systemic adverse events within 14 days postvaccination.

Figure 1. Subject disposition.

Figure 1. Subject disposition.

Figure 2. PCV15-A and PCV15-B versus PCV13 OPA GMT ratios at 1 month postvaccination.

Figure 2. PCV15-A and PCV15-B versus PCV13 OPA GMT ratios at 1 month postvaccination.

Figure 3. PCV15-A and PCV15-B versus PCV13 IgG GMC ratios at 1 month postvaccination.

Figure 3. PCV15-A and PCV15-B versus PCV13 IgG GMC ratios at 1 month postvaccination.

Table 2. Summary of OPA antibody responses – geometric mean fold rise (GMFR) (per protocol population).

Table 3. Summary of IgG antibody responses – GMFR (per protocol population).

Table 4. Summary of OPA antibody responses – %≥ 4 fold rise (per protocol population).

Figure 4. Serotype-specific OPA GMTs by age stratum [PCV15-A (left); PCV15-B (right)]

Figure 4. Serotype-specific OPA GMTs by age stratum [PCV15-A (left); PCV15-B (right)]
Supplemental material

Supplemental Material

Download Zip (665.1 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.